enGene
Founded 1999 · 136 employees on LinkedIn · 2 known investors
enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
Investors · 2
Competitors · 3
by search overlap
Adagene38 shared keywordsAdagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment. The company's platform generates novel antibodies aimed at improving safety and efficacy in precision-guided antibody-drug conjugates and other therapeutic approaches.
Origene34 shared keywordsOriGene supplies research reagents including primary antibodies for flow cytometry, transfection kits (EZ-LNP and ProteanFect), RNAi gene silencing tools, and control solutions for life science laboratories. Its products serve researchers in molecular and cell biology.
Enzene Biosciences Ltd28 shared keywordsEnzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals. It is a subsidiary of Alkem Laboratories and offers advanced manufacturing processes as a strategic partner for biologic products.
Companies competing with enGene for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does enGene do?
- enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
- Who are enGene's investors?
- enGene's investors include CTI Life Sciences Fund L.P., Lumira Ventures.